Encora Therapeutics
Pre-clinicalEncora Therapeutics develops novel therapies for neurological and rare diseases using targeted molecular approaches.
Founded
2021
Focus
NeuroscienceRare Disease
About
Encora Therapeutics develops novel therapies for neurological and rare diseases using targeted molecular approaches.
Funding History
2Total raised: $60M
Series A$50MMPM CapitalJan 15, 2023
Seed$10MMPM CapitalSep 15, 2021
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile